Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vascular pharmacology

Showing results (1-10 of 1,741) with videos related to

Pageof 175
Sort By:
Vascular Pharmacology|June 11, 2022
Quantitative and structural characteristics of mitochondrial DNA in varicose veinsMariya A Smetanina, Igor P Oscorbin, Alexandra S Shadrina, et al.
Vascular Pharmacology|October 5, 2010
Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient miceSung-E Choi, Hyun-Ju Jang, Yup Kang, et al.
Vascular Pharmacology|October 5, 2010
LPS from Porphyromonas gingivalis increases the sensitivity of contractile response mediated by endothelin-B (ET(B)) receptors in cultured endothelium-intact rat coronary arteriesBahareh Ghorbani, Palle Holmstrup, Lars Edvinsson, et al.
Vascular Pharmacology|September 4, 2010
PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesisVasiliki Koika, Zongmin Zhou, Ioannis Vasileiadis, et al.
Vascular Pharmacology|November 3, 2010
Combretastatin-induced hypertension and the consequences for its combination with other therapiesMorten Busk, Anja Bille Bohn, Marianne Skals, et al.
Vascular Pharmacology|March 29, 2011
Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytesStefan J Rauch, Anke C Rosenkranz, Andreas Böhm, et al.
Vascular Pharmacology|April 2, 2011
Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targetsRosalinda Madonna, Raffaele De Caterina
Vascular Pharmacology|June 4, 2019
Extended treatment with non-vitamin K antagonist oral anticoagulants versus low-molecular-weight heparins in cancer patients following venous thromboembolism. A pilot studyKonrad Stepien, Karol Nowak, Jaroslaw Zalewski, et al.
Vascular Pharmacology|June 2, 2019
Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL studyLoukman Omarjee, Estelle Le Pabic, Marc-Antoine Custaud, et al.
Vascular Pharmacology|July 5, 2015
Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatmentJanaina A Simplicio, Leonardo B Resstel, Daniela P C Tirapelli, et al.
Pageof 175

Showing results (1-10 of 1,741) with videos related to

Sort By:
Pageof 175
Vascular Pharmacology|June 11, 2022
Quantitative and structural characteristics of mitochondrial DNA in varicose veinsMariya A Smetanina, Igor P Oscorbin, Alexandra S Shadrina, et al.
Vascular Pharmacology|October 5, 2010
Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient miceSung-E Choi, Hyun-Ju Jang, Yup Kang, et al.
Vascular Pharmacology|October 5, 2010
LPS from Porphyromonas gingivalis increases the sensitivity of contractile response mediated by endothelin-B (ET(B)) receptors in cultured endothelium-intact rat coronary arteriesBahareh Ghorbani, Palle Holmstrup, Lars Edvinsson, et al.
Vascular Pharmacology|September 4, 2010
PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesisVasiliki Koika, Zongmin Zhou, Ioannis Vasileiadis, et al.
Vascular Pharmacology|November 3, 2010
Combretastatin-induced hypertension and the consequences for its combination with other therapiesMorten Busk, Anja Bille Bohn, Marianne Skals, et al.
Vascular Pharmacology|March 29, 2011
Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytesStefan J Rauch, Anke C Rosenkranz, Andreas Böhm, et al.
Vascular Pharmacology|April 2, 2011
Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targetsRosalinda Madonna, Raffaele De Caterina
Vascular Pharmacology|June 4, 2019
Extended treatment with non-vitamin K antagonist oral anticoagulants versus low-molecular-weight heparins in cancer patients following venous thromboembolism. A pilot studyKonrad Stepien, Karol Nowak, Jaroslaw Zalewski, et al.
Vascular Pharmacology|June 2, 2019
Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL studyLoukman Omarjee, Estelle Le Pabic, Marc-Antoine Custaud, et al.
Vascular Pharmacology|July 5, 2015
Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatmentJanaina A Simplicio, Leonardo B Resstel, Daniela P C Tirapelli, et al.
Pageof 175